| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.3737 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCCN(CCO)C1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=UUCMDZWCRNZCOY-UHFFFAOYSA-N
InChI=1S/C19H20N2O3/c22-13-11-21(12-14-23)19-20-17(15-7-3-1-4-8-15)18(24-19)16-9-5-2-6-10-16/h1-10,22-23H,11-14H2
| Molecular Formula | C19H20N2O3 |
| Molecular Weight | 324.3737 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Ditazole, a non-steroidal anti-inflammatory drug with anti-aggregation activity, is marketed under the brand name Ageroplas in Spain and Portugal. Ageroplas is indicated for the prophylaxis and treatment of thrombotic vasculopathy or thromboembolic arteriosclerosis, hypertension, diabetes mellitus, vascular nephropathy, and glomerular, cardiac and vascular prostheses, phlebitis and thrombophlebitis. Ditazole also possesses analgesic and antipyretic activity.
